Dr. Zhao is Chairman and Professor of Medicine, and Cheung Kong Scholar, The Center of Excellence in Tissue Engineering, Chinese Academy Medical Sciences and Peking Union Medical College. Chief scientist of National 973 Basic Research Program of the MOST. Regional Editor, Stem Cells and Development (USA), Director, The Beijing Key Laboratory of New Drug Development and Clinical Trial of Stem Cell Therapy. He is selected into Elsevier’s list of highly cited scholars in the disciplines of “biochemistry, genetics and molecular biology” in China for 8 consecutive years from 2014 to 2021, Dr. Zhao has made significant progress in understanding the biological characteristics of MSCs as well as stem cell clinical trials in China, and he has published more than 200 full scientific articles in peer-reviewed journals, cited by Nature for more than 5000 times totally with H index 63. Dr. Zhao also received several national awards, including the Second Prize of the National Invention Award by the State Council of China.